Hims & Hers Health

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

Retrieved on: 
Monday, December 4, 2023
Health, Telemedicine, Virtual Medicine, Fitness & Nutrition, General Health, Vitamins, Supplements, Pharmaceutical, Topiramate, Metformin, Hims & Hers Health, Sleep, Obesity, Depression, Research, NYSE, FACP, Naltrexone, Major trauma, Medication, Psychology, Gambling, Overweight, Patient, Multimedia, FAAP, Movement, FOMA, Motivation, Weight gain, Digital, Weight loss, MD, CDC, SVP, Heart Health Park, Vitamin B12, Birth control, Nursing, Dietary supplement, Behavior, Hers, Bupropion

View the full release here: https://www.businesswire.com/news/home/20231204073836/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231204073836/en/
    Weight Loss by Hims & Hers (Graphic: Business Wire)
    The science-backed Weight Loss by Hims & Hers program is developed with the expert insight of Dr. Primack and a team of clinical experts in obesity medicine, psychology and nutrition.
  • The program offers a well-rounded and more affordable approach to reducing weight by addressing the underlying factors that affect people’s weight – Nutrition, Behavior, Movement and Medical Treatment.
  • Weight Loss by Hims & Hers aims to address these issues by taking on the physical and psychological factors that contribute to weight gain and loss.
  • For more information on Hims & Hers’ weight loss program, please visit https://www.forhers.com/weight-loss and https://www.hims.com/c/wm/introduction .

SHOWFIELDS DC Unveils Holiday 2023 Brand Collection

Retrieved on: 
Wednesday, November 15, 2023
Hims & Hers Health, Household, Hers, Beauty, Health, Seventh generation, CLEAN, Retail

WASHINGTON, Nov. 15, 2023 /PRNewswire/ -- SHOWFIELDS DC is thrilled to introduce its latest curation, just in time for the holiday season. This month, over fifty outstanding brands make their debut in-store, offering an eclectic blend of the finest in fashion, beauty, wellness, gifts, and more.

Key Points: 
  • WASHINGTON, Nov. 15, 2023 /PRNewswire/ -- SHOWFIELDS DC is thrilled to introduce its latest curation, just in time for the holiday season.
  • Now approaching its one-year anniversary in Georgetown, SHOWFIELDS will continue to add more brands throughout 2024 and will be hosting its signature programming and activations throughout the holiday season.
  • The well-loved brand will showcase already popular products in an interactive display as well as new goods to discover.
  • This American heritage apparel and home brand will be delighting DC customers with their iconic blankets, classic apparel, and more – just in time for the cold weather ahead.

Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Retrieved on: 
Monday, November 6, 2023
Mental Health, Women, Men, Health Technology, Telemedicine, Virtual Medicine, Health, Consumer, Pharmaceutical, General Health, Adjustment, Regulation S-K, EBITDA, Hers, Table, GAAP, Hims & Hers Health, Regulation, Video game, Bookkeeping, Beauty salon

Gross margin was 83% for the third quarter of 2023 compared to 79% for the third quarter of 2022.

Key Points: 
  • Gross margin was 83% for the third quarter of 2023 compared to 79% for the third quarter of 2022.
  • Net loss was $(7.6) million for the third quarter of 2023 compared to $(18.8) million for the third quarter of 2022.
  • Adjusted EBITDA was $12.3 million for the third quarter of 2023 compared to $(6.1) million for the third quarter of 2022.
  • Hims & Hers will host a conference call to review the third quarter 2023 results on November 6, 2023, at 5:00 p.m.

Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization

Retrieved on: 
Monday, November 6, 2023
Health, Telemedicine, Virtual Medicine, Health Technology, Other Health, Fitness & Nutrition, General Health, Pharmaceutical, Hers, Hims & Hers Health, NYSE, Share repurchase, Entrepreneurship, Growth, Investment

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years.

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers” or the “Company,” NYSE: HIMS), the leading health and wellness platform, today announced that its Board of Directors has authorized a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years.
  • This repurchase program may be commenced, suspended or discontinued at any time.
  • Revenue was up 57% year-over-year in the third quarter to $226.7 million, and the Company surpassed 1.4 million subscribers.
  • For the full year, revenue is expected to be between $868 and $873 million, up 65% to 66% year-over-year.

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

Retrieved on: 
Monday, November 6, 2023
Software, Men, Internet, Professional Services, Consumer, Mental Health, Technology, Artificial Intelligence, Health Technology, Data Analytics, Women, Health, Commission, Intelligence, Hers, Security (finance), Education, Hims & Hers Health, NYSE, Data, Acquisition, App Store (iOS/iPadOS), Entrepreneurship, Multimedia, Nature, Homs, Growth, Machine learning, DSM-IV codes, Privacy, Patient satisfaction, Depression, Anxiety, Annual report, Investment, Patient, Medical device, Nursing, Pharmaceutical industry, Risk management

View the full release here: https://www.businesswire.com/news/home/20231106108871/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231106108871/en/
    Currently in Beta, MedMatch deploys artificial intelligence and machine learning against the expansive dataset at the core of the Hims & Hers platform.
  • The company is initially deploying MedMatch for customers seeking support for anxiety and depression on the Hims & Hers platform.
  • Many people avoid seeking treatment due to stigma and lack of education for psychiatric disorders.
  • When treatment is sought, there is a shortage of mental health professionals, creating an unacceptable gap between need and access.

Hims & Hers Names Khobi Brooklyn As Chief Communications Officer

Retrieved on: 
Thursday, October 19, 2023
Telemedicine, Virtual Medicine, Pharmaceutical, General Health, Health, Mental Health, Health Technology, Technology, Fitness & Nutrition, Child, Hers, Hims & Hers Health, NYSE, SVP, Square, Family, Tesla, CCO, Nike, Communication, Multimedia, Homs, Transport, Parental leave, Culture, Converse, Tourism

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced communications veteran Khobi Brooklyn will further position Hims & Hers at the forefront of personalized healthcare as its Chief Communications Officer.

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced communications veteran Khobi Brooklyn will further position Hims & Hers at the forefront of personalized healthcare as its Chief Communications Officer.
  • In her role as CCO, Brooklyn will strengthen the Hims & Hers brand and increase awareness by spearheading the company’s communications function which includes corporate, consumer and internal, reporting to the CEO.
  • View the full release here: https://www.businesswire.com/news/home/20231019667026/en/
    Hims & Hers Chief Communications Officer Khobi Brooklyn (Photo: Business Wire)
    “Hims & Hers has an incredible story to tell, and I’m thoroughly excited to help more people understand the benefits of our offerings,” said Brooklyn.
  • Prior to Aurora, Brooklyn was VP of Communications at Nike leading communications for the Converse brand.

Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023

Retrieved on: 
Monday, October 16, 2023
Mental Health, Health, Telemedicine, Virtual Medicine, Health Technology, General Health, Pharmaceutical, Hims & Hers Health, NYSE, Tourism, Video game

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023.

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report third quarter 2023 financial results after the market closes on Monday, November 6, 2023.
  • The company will host a live conference call to discuss the results at 5:00 p.m.
  • The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referencing conference ID 1704296.
  • A live audio webcast will be available at https://investors.hims.com and will be archived for one year.

Hims & Hers Named on Fortune Media and Great Place to Work’s 2023 Best Workplaces in Health Care List

Retrieved on: 
Wednesday, September 6, 2023
Professional Services, Business, Health, Telemedicine, Virtual Medicine, Human Resources, General Health, Hims & Hers Health, Organization, Hers, Work, Great Places, Homs, NYSE, Nursing, Management

Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Great Place To Work® and Fortune magazine named the company on the 2023 Fortune Best Workplaces in Health Care™ List .

Key Points: 
  • Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Great Place To Work® and Fortune magazine named the company on the 2023 Fortune Best Workplaces in Health Care™ List .
  • The Best Workplaces in Health Care award is based on analysis of survey responses from over 208,000 employees from Great Place To Work Certified™ companies in the healthcare industry.
  • Earning a spot means that Hims & Hers is one of the best companies to work for in the country.
  • “Congratulations to the Best Workplaces in Health Care,” says Michael C. Bush, CEO of Great Place To Work.

60% of Patients Trust Independent Practices Over Corporate Healthcare, Despite Valuing Speedy Care

Retrieved on: 
Tuesday, August 22, 2023
Health, Technology, Health Technology, Other Technology, Telecommunications, Software, General Health, Telehealth, Communication, Marketing, CVS, Hims & Hers Health, Patient, Software Advice, BetterHelp, MinuteClinic, UnitedHealth Group, Social media, SmileDirectClub, Medical imaging, Nursing, Pharmaceutical industry, Amazon

Although large providers offer rapid and streamlined services, independent practices hold a trust advantage, with 60% of patients expressing greater confidence in them.

Key Points: 
  • Although large providers offer rapid and streamlined services, independent practices hold a trust advantage, with 60% of patients expressing greater confidence in them.
  • By leveraging technology, practices can harness their strengths in patient trust and personal connection to gain an edge on corporate practices.
  • Beyond integrating modern tools, healthcare practices have the opportunity to sway 54% of patients with no preference between independent or corporate practices by applying smart marketing strategies that highlight the numerous benefits independent practices provide.
  • View the full report on Software Advice to learn more about how independent practices can compete successfully against corporate providers.

Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Retrieved on: 
Monday, August 7, 2023
Health, General Health, Hims & Hers Health, Net, Hers, EBITDA, Adjustment, GAAP, Table, Video game, Bookkeeping, Beauty salon

Gross margin was 82% for the second quarter of 2023 compared to 77% for the second quarter of 2022.

Key Points: 
  • Gross margin was 82% for the second quarter of 2023 compared to 77% for the second quarter of 2022.
  • Net loss was $(7.2) million for the second quarter of 2023 compared to $(19.7) million for the second quarter of 2022.
  • Adjusted EBITDA was $10.6 million for the second quarter of 2023 compared to $(7.5) million for the second quarter of 2022.
  • Hims & Hers will host a conference call to review the second quarter 2023 results on August 7, 2023, at 5:00 p.m.